These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 10921933)

  • 1. Nationwide German multicenter study on prevalence of antibiotic resistance in staphylococcal bloodstream isolates and comparative in vitro activities of quinupristin-dalfopristin.
    von Eiff C; Reinert RR; Kresken M; Brauers J; Hafner D; Peters G
    J Clin Microbiol; 2000 Aug; 38(8):2819-23. PubMed ID: 10921933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro activity of quinupristin/dalfopristin in comparison with five antibiotics against worldwide clinical isolates of staphylococci.
    Auckenthaler R; Courvalin P; Féger C; Roche G;
    Clin Microbiol Infect; 2000 Nov; 6(11):608-12. PubMed ID: 11168064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimicrobial susceptibility of quinupristin/dalfopristin tested against gram-positive cocci from Latin America: results from the global SMART (GSMART) surveillance study.
    Sader HS; Jones RN; Ballow CH; Biedenbach DJ; Cered RF;
    Braz J Infect Dis; 2001 Feb; 5(1):21-31. PubMed ID: 11290311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activity of antimicrobial agents against oxacillin resistant staphylococci with special reference to Staphylococcus haemolyticus.
    Chaudhury A; Kumar AG
    Indian J Med Microbiol; 2007 Jan; 25(1):50-2. PubMed ID: 17377353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative in vitro activity of quinupristin/dalfopristin and seven other antimicrobials against methicillin-susceptible and methicillin-resistant nosocomial Staphylococcus aureus bloodstream isolates.
    Nikolaidis P; Metallidis S; Katikaridou E; Chatzidimitriou M; Kollaras P; Tsona A; Koumentaki E; Tourkantonis A
    J Chemother; 2002 Dec; 14(6):544-6. PubMed ID: 12583543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial activity of quinupristin-dalfopristin (RP 59500, Synercid) tested against over 28,000 recent clinical isolates from 200 medical centers in the United States and Canada.
    Jones RN; Ballow CH; Biedenbach DJ; Deinhart JA; Schentag JJ
    Diagn Microbiol Infect Dis; 1998 Jul; 31(3):437-51. PubMed ID: 9635235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro study of the potential role of quinupristin/dalfopristin in the treatment of catheter-related staphylococcal infections.
    Garcia R; Raad I
    Eur J Clin Microbiol Infect Dis; 1996 Dec; 15(12):933-6. PubMed ID: 9031876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quinupristin-dalfopristin resistance among gram-positive bacteria in Taiwan.
    Luh KT; Hsueh PR; Teng LJ; Pan HJ; Chen YC; Lu JJ; Wu JJ; Ho SW
    Antimicrob Agents Chemother; 2000 Dec; 44(12):3374-80. PubMed ID: 11083643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activity of quinupristin/dalfopristin, linezolid, telithromycin and comparator antimicrobial agents against 13 species of coagulase-negative staphylococci.
    John MA; Pletch C; Hussain Z
    J Antimicrob Chemother; 2002 Dec; 50(6):933-8. PubMed ID: 12461014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative activities of daptomycin and several agents against staphylococcal blood isolates. Glycopeptide tolerance.
    Picazo JJ; Betriu C; Rodríguez-Avial I; Culebras E; López-Fabal F; Gómez M;
    Diagn Microbiol Infect Dis; 2011 Jul; 70(3):373-9. PubMed ID: 21683269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparative activity of daptomycin against clinical isolates of methicillin-resistant Staphylococcus aureus and coagulase-negative staphylococci].
    Picazo JJ; Betriu C; Rodríguez-Avial I; Culebras E; López F; Gómez M;
    Enferm Infecc Microbiol Clin; 2010 Jan; 28(1):13-6. PubMed ID: 19406529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activity of telithromycin and quinupristin/dalfopristin against methicillin-resistant coagulase-negative staphylococci with defined resistance genotypes.
    Novotná G; Spízek J; Janata J
    Folia Microbiol (Praha); 2007; 52(6):593-9. PubMed ID: 18450221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of linezolid & quinupristin/dalfopristin against Gram-positive cocci.
    Tünger A; Aydemir S; Uluer S; Cilli F
    Indian J Med Res; 2004 Dec; 120(6):546-52. PubMed ID: 15654141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative in-vitro activities of quinupristin-dalfopristin against Gram-positive bloodstream isolates.
    Schouten MA; Hoogkamp-Korstanje JA
    J Antimicrob Chemother; 1997 Aug; 40(2):213-9. PubMed ID: 9301986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Occurrence of macrolide-lincosamide-streptogramin resistances among staphylococcal clinical isolates at a university medical center. Is false susceptibility to new macrolides and clindamycin a contemporary clinical and in vitro testing problem?
    Sanchez ML; Flint KK; Jones RN
    Diagn Microbiol Infect Dis; 1993; 16(3):205-13. PubMed ID: 8477574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activities of the combination of quinupristin-dalfopristin with rifampin in vitro and in experimental endocarditis due to Staphylococcus aureus strains with various phenotypes of resistance to macrolide-lincosamide-streptogramin antibiotics.
    Zarrouk V; Bozdogan B; Leclercq R; Garry L; Feger C; Carbon C; Fantin B
    Antimicrob Agents Chemother; 2001 Apr; 45(4):1244-8. PubMed ID: 11257041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In-vitro bactericidal activity of quinupristin/dalfopristin alone and in combination against resistant strains of Enterococcus species and Staphylococcus aureus.
    Kang SL; Rybak MJ
    J Antimicrob Chemother; 1997 May; 39 Suppl A():33-9. PubMed ID: 9511060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative in-vitro activities of moxifloxacin, trovafloxacin, quinupristin/dalfopristin and linezolid against staphylococci.
    von Eiff C; Peters G
    J Antimicrob Chemother; 1999 Apr; 43(4):569-73. PubMed ID: 10350389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vancomycin heteroresistance in coagulase negative Staphylococcus blood stream infections from patients of intensive care units in Mansoura University Hospitals, Egypt.
    Mashaly GE; El-Mahdy RH
    Ann Clin Microbiol Antimicrob; 2017 Sep; 16(1):63. PubMed ID: 28927452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prevalence of staphylococcal resistance to penicillinase-resistant penicillins. A retrospective and prospective national surveillance trial of isolates from 40 medical centers.
    Jones RN; Barry AL; Gardiner RV; Packer RR
    Diagn Microbiol Infect Dis; 1989; 12(5):385-94. PubMed ID: 2533050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.